{{Rsnum
|rsid=2058660
|Gene=IL18RAP
|Chromosome=2
|position=102437989
|Orientation=plus
|GMAF=0.2778
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL18RAP
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.5 | 32.7 | 63.7
| HCB | 20.6 | 51.5 | 27.9
| JPT | 10.7 | 56.2 | 33.0
| YRI | 0.7 | 10.2 | 89.1
| ASW | 0.0 | 7.1 | 92.9
| CHB | 20.6 | 51.5 | 27.9
| CHD | 23.9 | 54.1 | 22.0
| GIH | 16.0 | 53.0 | 31.0
| LWK | 0.0 | 27.3 | 72.7
| MEX | 12.3 | 57.9 | 29.8
| MKK | 3.2 | 30.1 | 66.7
| TSI | 5.0 | 28.7 | 66.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21102463
|Trait=None
|Title=Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|RiskAllele=G
|Pval=2E-12
|OR=1.1900
|ORtxt=[1.14-1.26]
|OA=1
}}

{{PMID Auto
|PMID=23103228
|Title=Identification of IL18RAP/IL18R1 and IL12B as leprosy risk genes demonstrates shared pathogenesis between inflammation and infectious diseases.
|OA=1
}}

{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}